Status:
UNKNOWN
Pathogenic Microorganisms in Adult Severe Pneumonia Patients
Lead Sponsor:
Shengjing Hospital
Collaborating Sponsors:
Chaoyang Central Hospital
Yingkou Central Hospital
Conditions:
Pathogenic Microorganism of Serious Pneumonia
Eligibility:
All Genders
18+ years
Brief Summary
This study aimed to evaluate pathogenic microorganisms in adult severe pneumonia patients in different cities of Liaoning Province
Detailed Description
The pathogenic microorganisms of adult patients with severe pneumonia is detected in this study. Clinical treatment does not involve , so it meets the ethical requirements. The clinical data, laborato...
Eligibility Criteria
Inclusion
- Meet the standard of severe pneumonia： Main standards： Requiring mechanical ventilation or septic shock requiring vasoconstrictor therapy.
- Secondary standards：(only if 3 items are met) Disturbance of consciousness; respiratory rate ≥ 30 times/min; PaO2/FiO2 ≤ 250, or PaO2 \< 60mmHg; azotemia (BUN ≥ 7.12mmol / L); hypotension requires strong fluid resuscitation; infiltration of multiple lobes; leucopenia (WBC \< 4 × 109 / L); thrombocytopenia (\< 10 × 109 / L); hypothermia (T \< 36 ℃).
Exclusion
- refuse to sign informed consent; inaccurate results due to unqualified sputum or BALF samples
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04433403
Start Date
July 1 2020
End Date
June 30 2024
Last Update
September 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shengjing hospital of China Medical University
Shenyang, Liaoning, China, 110004